HomeInsightsMarket Capitalization

Market Capitalization of Mesco Pharmaceuticals Ltd

Market Capitalization of Mesco Pharmaceuticals Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Jan 10, 2022)

stocks purchased

0.7 K

Stocks Traded

(Jan 10, 2022)

Last Updated on: Nov 14, 2024

Image

Mesco Pharmaceuticals Ltd

NSE: MESCOPHARM

MARKETCAP

₹ 9.23 crore

Last updated on: Jan 10, 2024

Key Highlights

  • The Market Cap of Mesco Pharmaceuticals Ltd is ₹ 9.23 crore as of 10 Jan 22.
  • The Market Cap of Mesco Pharmaceuticals Ltd changed from ₹ 0 crore on March 2019 to ₹ 0 crore on March 2021 . This represents a CAGR of 0.0% over 3 years. .
  • The Latest Trading Price of Mesco Pharmaceuticals Ltd is ₹ 4.54 as of 10 Jan 15:30.

Historical Market Cap of Mesco Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Mesco Pharmaceuticals Ltd

No data available

Image

Mesco Pharmaceuticals Ltd

NSE: MESCOPHARM

PRICE

₹ 4.54

0.21 (4.85%)

stock direction

Last updated on: Jan 10 03:30 PM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Mesco Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Jan 20224.54
28 Oct 20214.33
27 Oct 20214.55
26 Oct 20214.7
22 Oct 20214.74
19 Oct 20214.65
12 Oct 20214.65
07 Oct 20214.89
06 Oct 20215.14
05 Oct 20215.41

SWOT Analysis Of Mesco Pharmaceuticals Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Mesco Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Mesco Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Mesco Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Mesco Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Mesco Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Mesco Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Mesco Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Mesco Pharmaceuticals Ltd

  • Mesco Pharmaceuticals started commercial operations in Jun.'91 by venturing into seed-marketing of bulk drugs and formulations with the objective of later establishing facilities for manufacture of bulk drugs and formulations.
  • It set up a formulation plant to manufacture injectables, syrups, ointments and tablets/capsules. The company in technical partnership with Merz, Germany, introduced two drugs -- Hepa Merz and Viru Merz -- for hepatitis (liver disorder) and herpes respectively.
  • It is now developing drugs for cardio-vascular diseases and Parkinson's disease.
  • Apart from Merz, Mesco has technical agreements with two Chinese companies -- Guilin Pharmaceutical Factory and China Science & Resources Technology Trading Corporation. The company has expanded its marketing network to the CIS, Italy, Germany and Africa.

Mesco Pharmaceuticals Ltd News Hub

News

Mesco Pharmaceuticals to discuss results

Mesco Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 F...

Read more

10 Feb 202209:58

News

Mesco Pharmaceuticals schedules board meeting

Mesco Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 N...

Read more

09 Nov 202117:18

News

Mesco Pharmaceuticals schedules AGM

Mesco Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will ...

Read more

16 Sep 202118:21

News

Mesco Pharmaceuticals to convene board meeting

Mesco Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 Se...

Read more

06 Sep 202110:13

News

Mesco Pharmaceuticals to conduct board meeting

Mesco Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 J...

Read more

25 Jun 202111:17

News

Mesco Pharmaceuticals to table results

Mesco Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 F...

Read more

04 Feb 202116:41

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Mesco Pharmaceuticals Ltd Market Cap

What is the market cap of Mesco Pharmaceuticals Ltd?

As of November 14, 2024, Mesco Pharmaceuticals Ltd has a market capitalization of ₹9.23, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Mesco Pharmaceuticals Ltd's market capitalization?

Mesco Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Mesco Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Mesco Pharmaceuticals Ltd's market capitalization change?

Mesco Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*